COSCIENS Biopharma reported cash from operations of -$1.47M and free cash flow of -$1.52M for the quarter ended Dec 2025, up 51.0% year over year. This cash flow statement covers 31 quarters of results from Jun 2018 through Dec 2025, standardized by Business Quant from the company’s SEC filings.
| Cash Flow Statement | Jun2018 | Sep2018 | Dec2018 | Mar2019 | Jun2019 | Sep2019 | Dec2019 | Mar2020 | Jun2020 | Sep2020 | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||||||||||||||||||||||||||
| Net Income | -1.46M | -2.08M | -1.93M | -2.89M | -2.64M | -4.22M | -3.42M | 13.72M | -4.25M | -0.86M | -0.78M | -1.56M | -1.40M | -1.42M | -5.75M | -6.73M | -3.65M | -2.70M | -1.82M | -2.18M | |||||||||||
| Share-based CompensationStock Comp. | 0.01M | 0.26M | 0.02M | 0.02M | 0.03M | 0.03M | 0.44M | -0.43M | 0.02M | 0.04M | 0.03M | 0.02M | 0.01M | 0.01M | 0.43M | 0.01M | 0.01M | -0.09M | -0.02M | 0.09M | |||||||||||
| Change in Working CapitalChange Working Cap. | -1.65M | 1.13M | -0.86M | 0.17M | 0.68M | -0.76M | 0.12M | -0.74M | -0.37M | 0.96M | -1.82M | 4.12M | -0.75M | -1.33M | 2.42M | -0.95M | -0.44M | ||||||||||||||
| Change in ReceivablesChange Receivables | 0.65M | -0.47M | 0.26M | -0.20M | -0.18M | 0.20M | 0.99M | 0.43M | 0.50M | -1.11M | 0.43M | -0.98M | -0.02M | 1.10M | -0.61M | 1.71M | -1.06M | ||||||||||||||
| Change in InventoryChange Inventory | -0.04M | 0.21M | -0.04M | -1.25M | 0.01M | -0.67M | -0.17M | 0.05M | 0.39M | 0.50M | -0.21M | 0.42M | 0.24M | 0.77M | -0.06M | 0.47M | |||||||||||||||
| Change in Account PayablesChange Payables | 0.12M | -0.16M | 0.04M | 0.13M | 0.79M | 0.23M | -0.49M | 0.56M | -0.01M | -0.12M | 0.56M | -3.57M | 0.16M | 0.24M | -2.19M | -0.93M | 0.43M | ||||||||||||||
| Cash from OperationsCash from Ops. | -1.04M | -3.63M | -1.49M | -2.41M | -1.46M | -4.85M | -3.94M | 15.48M | -4.06M | -0.81M | 0.14M | -1.08M | -2.38M | -1.39M | -7.78M | -3.00M | -1.88M | -4.45M | -0.68M | -1.47M | |||||||||||
| Depreciation, Depletion & Amortization | |||||||||||||||||||||||||||||||
| Depreciation & Amortization (CF)Dep. & Amort. | 0.04M | 0.04M | 0.03M | 0.04M | 0.04M | 0.04M | 0.03M | 1.36M | 0.04M | 0.36M | 0.36M | 0.36M | 0.36M | 0.38M | 0.48M | 0.39M | 0.33M | 0.29M | 0.29M | 0.29M | |||||||||||
| Investing Activities | |||||||||||||||||||||||||||||||
| Capital ExpendituresCapex | 0.02M | 0.00M | 0.01M | 0.01M | 0.01M | 0.04M | 0.01M | 0.25M | 0.00M | 0.05M | 0.05M | 0.59M | 0.56M | 0.16M | 0.13M | 0.31M | 0.61M | 0.05M | -0.00M | 0.05M | |||||||||||
| Sales of Property, Plant and EquipmentPP&E (Sale) | 0.00M | 0.00M | 0.00M | 0.24M | |||||||||||||||||||||||||||
| Cash from Investing ActivitiesCash from Investing | -0.51M | -0.00M | -0.03M | -0.12M | -0.01M | -0.04M | -0.01M | -0.25M | -0.00M | -0.05M | -0.05M | -0.59M | -0.56M | 25.88M | 0.08M | -0.32M | -0.61M | -0.05M | 0.00M | 0.20M | |||||||||||
| Financing Activities | |||||||||||||||||||||||||||||||
| Cash from Financing ActivitiesCash from Financing | 50.93M | 0.02M | -0.03M | 0.11M | -0.03M | -0.03M | -0.03M | -0.17M | -0.04M | -0.07M | -0.06M | -0.17M | -0.09M | -0.13M | -0.19M | -0.20M | -0.20M | -0.11M | -0.09M | -0.01M | |||||||||||
| Additional items | |||||||||||||||||||||||||||||||
| Exchange Rate EffectFX Effect | -0.28M | 0.11M | -0.32M | -0.28M | -0.20M | -0.51M | -0.36M | 0.45M | 0.05M | 0.18M | -0.21M | 0.16M | -0.13M | -0.07M | 0.08M | -0.09M | 0.06M | 0.18M | -0.05M | 0.07M | |||||||||||
| Change in Cash | 49.10M | -3.50M | -1.87M | -2.70M | -1.70M | -5.44M | -4.34M | 15.52M | -4.05M | -0.76M | -0.17M | -1.69M | -3.17M | 24.30M | -7.81M | -3.60M | -2.63M | -4.42M | -0.81M | -1.22M | |||||||||||
| Free Cash FlowFCF | -1.06M | -3.64M | -1.49M | -2.42M | -1.47M | -4.89M | -3.95M | 15.24M | -4.06M | -0.87M | 0.09M | -1.67M | -2.94M | -1.55M | -7.91M | -3.31M | -2.50M | -4.50M | -0.67M | -1.52M | |||||||||||
| Net Cash FlowNCF | 49.38M | -3.61M | -1.54M | -2.43M | -1.50M | -4.93M | -3.98M | 15.07M | -4.10M | -0.94M | 0.04M | -1.84M | -3.04M | 24.36M | -7.88M | -3.52M | -2.69M | -4.60M | -0.76M | -1.28M |
Pull COSCIENS Biopharma's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/statements?ticker=CSCIF&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/statements"
params = {"ticker": "CSCIF", "statement": "CF", "frequency": "Quarter", "period": "all", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/statements?ticker=CSCIF&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEY");
const data = await res.json();